Literature DB >> 19165091

A novel TGF-beta antagonist speeds reepithelialization and reduces scarring of partial thickness porcine burns.

Adam J Singer1, Shuan S Huang, Jung S Huang, Steve A McClain, Alexander Romanov, Jean Rooney, Tom Zimmerman.   

Abstract

Scar formation after thermal injury is common and results in significant aesthetic and functional impairment. Transforming growth factor beta (TGF-beta) plays a significant role in scar formation. We tested the hypothesis that a novel TGF-beta peptantagonist would reduce scar formation and wound contraction in partial thickness burns by using a randomized controlled experiment. The subjects include two domestic pigs (20-25 kg). Forty burns were created on the animal's dorsum using an aluminum bar preheated to 80 degrees C and applied for 20 seconds resulting in a partial thickness thermal burn extending half way down the dermis. Burns were treated every other day for 1 week, then twice weekly for 3 weeks with a topical TGF-beta antagonist or its vehicle. Full thickness biopsies were obtained from all burns at 7, 10, and 14 days after injury. The wounds were completely excised after 28 days for histological assessment. Wound sections were stained with H&&E and evaluated by a dermatopathologist masked to treatment assignment for reepithelialization and depth of scar formation. We also determined the number of wounds at 28 days that healed with contracted, hour-glass shaped scars. Data were compared with chi and t-tests. Twenty burns were treated with TGF-beta antagonist and 20 with control vehicle. TGF-beta antagonist increased the percentage of completely reepithelialized wounds at 14 days (90 vs 45%, P = .002) and reduced the percentage of contracted wounds (35 vs 65%, P = .02) and full thickness scars (10 vs 60%, P = .002) at 28 days. Treatment of partial thickness porcine burns with the TGF-beta antagonist speeds reepithelialization and reduces scar formation and wound contraction in partial thickness porcine burns.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19165091     DOI: 10.1097/BCR.0b013e31819a6369

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  20 in total

1.  Guiding epithelial cell phenotypes with engineered integrin-specific recombinant fibronectin fragments.

Authors:  Ashley C Brown; Jessica A Rowe; Thomas H Barker
Journal:  Tissue Eng Part A       Date:  2010-12-12       Impact factor: 3.845

Review 2.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

3.  Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model.

Authors:  Elizabeth J Brisbois; Jill Bayliss; Jianfeng Wu; Terry C Major; Chuanwu Xi; Stewart C Wang; Robert H Bartlett; Hitesh Handa; Mark E Meyerhoff
Journal:  Acta Biomater       Date:  2014-06-28       Impact factor: 8.947

Review 4.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

5.  Validation of a vertical progression porcine burn model.

Authors:  Adam J Singer; Douglas Hirth; Steve A McClain; Laurie Crawford; Fubao Lin; Richard A F Clark
Journal:  J Burn Care Res       Date:  2011 Nov-Dec       Impact factor: 1.845

6.  The 800-nm diode laser irradiation induces skin collagen synthesis by stimulating TGF-β/Smad signaling pathway.

Authors:  Yongyan Dang; Bei Liu; Lianxi Liu; Xiyun Ye; Xinling Bi; Yong Zhang; Jun Gu
Journal:  Lasers Med Sci       Date:  2011-09-04       Impact factor: 3.161

Review 7.  Nonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation?

Authors:  Wen-Hsiang Su; Ming-Huei Cheng; Wen-Ling Lee; Tsung-Shan Tsou; Wen-Hsun Chang; Chien-Sheng Chen; Peng-Hui Wang
Journal:  Mediators Inflamm       Date:  2010-07-04       Impact factor: 4.711

8.  DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.

Authors:  Shuan Shian Huang; Chun-Lin Chen; Franklin W Huang; Wei-Hsien Hou; Jung San Huang
Journal:  J Cell Biochem       Date:  2016-02-18       Impact factor: 4.429

9.  SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.

Authors:  Gui-Fang Sun; Hong-Chang Li; Yue-Ping Zhan; Xiao-Fen Zhang; Li-Yun Pan; Ya-Feng Chen; Ke Xu; Dian-Xu Feng
Journal:  Lab Invest       Date:  2019-08-13       Impact factor: 5.662

Review 10.  Strategies Demonstrating Efficacy in Reducing Wound Contraction In Vivo.

Authors:  Justin R Sharpe; Yella Martin
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-05       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.